Volume 16, Number 2—February 2010
Severe Leptospirosis in Hospitalized Patients, Guadeloupe
We evaluated prognostic factors for leptospirosis in 168 consecutive hospitalized patients in Guadeloupe. Factors independently associated with severity included chronic hypertension or chronic alcoholism, late initiation of antibacterial therapy, abnormal chest auscultation results, icterus, oligoanuria, disorders of consciousness, elevated aspartate aminotransferase levels, hyperamylasemia, and Leptospira interrogans serovar Icterohemorrhagiae.
Leptospirosis is a reemerging infectious disease in tropical and subtropical regions (1). In Guadeloupe, it has long been a major public health concern. Its incidence rate was ≈5.5/100,000 inhabitants per year from 1991 through 2002. Since 2003, this rate has greatly increased, peaking at 41.2/100,000 inhabitants in 2004 (2,3). The clinical features of leptospirosis vary and may progress to multiorgan failure and death (4). Initial clinical symptoms and laboratory test results associated with severe forms remain unclear. In this study, we focused on severe forms and determined prognostic factors that may help physicians in the early management of leptospirosis. We also characterized reservoir hosts by identifying the serovars of infecting strains. These findings will help establish appropriate control and prevention measures.
This study was conducted in the hospital of Pointe-à-Pitre (1,100 beds), a tertiary referral center for Guadeloupe and neighboring islands. The ethical committee of the hospital approved the study. All consecutive patients hospitalized from January 2003 and through December 2004 with confirmed leptospirosis were included; patients admitted to Guadeloupe’s other hospital (200 beds) were excluded. Leptospirosis was confirmed if 1 blood culture yielded Lesptospira spp. or if specific antibodies were detected with either a single titer of >400 with the microscopic agglutination test (MAT) and an in-house enzyme immunoassay (EIA) with an immunoglobulin (Ig) M titer >400 (5) or at least a 4-fold increase in the MAT titer between the acute and convalescent phases. Cases were considered severe if dialysis (in case of oliguria) or mechanical ventilation was required or if the patient died. Leptospira serovars were isolated and identified as previously described (3). Epidemiologic, clinical, and laboratory data were collected retrospectively from medical records taken at patient’s admission. Data were analyzed by using Epi Info (Centers for Disease Control and Prevention, Atlanta, GA, USA). A multiple stepwise logistic regression analysis (SPSS, Chicago, IL, USA) was performed for variables with a p value <0.2.
During the 2-year period, leptospirosis was diagnosed in 168 hospitalized patients. A total of 132 case-patients had specific antibodies (49 had a single MAT titer >400 and EIA IgM titer >400, and 83 showed a 4-fold increase in the MAT titer in paired serum samples); 36 cases were confirmed only by culture. Of the 132 case-patients testing positive for antibody, 19 were also positive for bacterial culture. All but 2 case-patients were residents of Guadeloupe; the other 2 were a tourist from Paris and a resident of the Dominica. The ethnic distribution of the study population was similar to that of the Guadeloupean population.
We assessed patients’ demographic, epidemiologic, and clinical characteristics (Table 1). Twenty-four (14%) cases were considered to be severe: 6 (25%) of these were fatal. Female case-patients were significantly older than male case-patients (mean 58.5 ± 17.9 and 47 ± 15.9 years, respectively; p = 0.01). Chronic alcoholism was common (39%), especially among the 6 case-patients who died (67%). Chronic hypertension was also frequent (32%) (Table 1). The most common symptoms were myalgia (95%), headache (77%), digestive disorders (63%), fever (57%), abdominal pain (52%), and icterus (49%). Alveolar infiltrates was the most common feature, accounting for 9 (41%) of 22 anomalies observed in the lung by chest radiograph, followed by interstitial pattern (27%) and pleural suffusion (18%). Six case-patients with severe disease had cardiac complications: 2 had pericarditis confirmed by echocardiography, 2 had ischemic cardiac shock, and 2 myocardiopathy and myocarditis. Tomodensitometry or ultrasonography showed acute pancreatitis in 10 case-patients, of whom 6 had chronic alcoholism and 3 had severe disease. Thrombocytopenia (<150 × 109 cells/L) was common (90% of case-patients), with severe thrombocytopenia (<50 × 109 cells/L) observed in 19% of case-patients (Table 2). Hepatic cytolysis (alanine aminotransferase level >119 U/L or aspartate aminotransferase level >102 U/L) was found in 45% of case-patients. One fifth of case-patients exhibited rhabdomyolysis with creatinine phosphokinase levels >1,000 U/L (Table 2). The L. interrogans serovar Icterohemorrhagiae was found in 18 (45%) of the 40 case-patients for whom serovars were identified. The closely related L. borgpetersenii serovars Arborea and Castellonis accounted for 35% of identified strains (Table 2).
Univariate analysis showed that, after stratification for sex, severity was associated with age for women but not for men. Neither occupation (farming, livestock farming, construction, and gardening) nor contact with swine, cattle, or rodents was linked to severity (Table 1). Nine host-related factors (listed in order of decreasing odds ratio) remained independently associated with severity in the multivariate analysis: history of chronic hypertension, hyperamylasemia, history of chronic alcoholism, abnormalities at chest auscultation, oligoanuria, late initiation (>10 days after onset of symptoms) of antibacterial therapy, elevated aspartate aminotransferase levels, consciousness disorders, and icterus. Chronic alcoholism was linked to death (p<0.01). The L. interrogans serovar Icterohemorrhagiae was isolated in 75% of severe cases, but in only 38% of nonsevere cases, and was independently associated with severity.
The potential correlation between disease severity and Leptospira serovar remains a matter of debate. The L. interrogans serovars Icterohemorrhagiae, Canicola, and Australis have been linked to severity and multiorgan failure (6–8), but other studies did not confirm any link between serovar and outcome (9–11). L. Icterohemorrhagiae was clearly linked to disease severity. Therefore, a diagnostic test specifically detecting this serovar at an early stage of disease could help in the management of leptospirosis in patients in Guadeloupe. We confirmed that the L. borgpetersenii serovars Arborea and Castellonis, rarely isolated elsewhere, are highly prevalent in Guadeloupe (3,12). Taken together, they are the second most prevalent serovars after Icterohemorrhagiae. Notably, the serogroup Ballum, comprising the serovars Arborea and Castellonis, also is one of the main serogroups associated with human infections in Barbados (9). The serovar Arborea has been associated with mice, particularly in Barbados (1,13). In Guadeloupe, this serovar has been isolated from mice and rats, and the serovars Icterohemorrhagiae and Bogvere have been isolated from rats (3; V. Michelle, pers. comm.). Thus, rodent populations may be the main source of Leptospira spp. in Guadeloupe. Further animal studies are needed to establish the nature of these Leptospira reservoirs.
Chronic hypertension has not previously been found to predict poor prognosis for leptospirosis. Here, we found it to be the strongest risk factor for severe disease. Whether patients with histories of chronic hypertension are especially susceptible remains to be confirmed.
In our series of patients, acute hepatitis and pancreatitis were severe complications of leptospirosis in those with chronic alcoholism; chronic alcoholism itself was an independent indicator of poor prognosis. These results are consistent with findings from other studies conducted in La Réunion, another French overseas territory, and in continental France (14,15).
Patients with chronic hypertension or chronic alcoholism, late initiation of antibacterial therapy, consciousness disorders, abnormal features at chest auscultation, oligoanuria, jaundice, hyperamylasemia, or high aspartate aminotransferase levels may benefit from early intensive and specific management. The predominance of the Icterohemorrhagiae serovar, linked to severe disease, and of the Arborea and the Castellonis serovars highlights the need for rodent control to reduce the effects of leptospirosis in Guadeloupe.
Dr Herrmann-Storck is a physician and microbiologist in the laboratory of Microbiology at the teaching hospital of Pointe-à-Pitre, Guadeloupe, French West Indies. Her principal research interests are leptospirosis epidemiology; human T-lymphocyte virus epidemiology; and infections with arboviruses, including dengue and West Nile virus.
This work was supported in part by the Institut National de Veille Sanitaire, through funding from the National Reference Centre for Leptospirosis.
- Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3:757–71.
- National Reference Centre for. Leptospira, Institut Pasteur, Paris, France. Epidemiology of leptospirosis in France in 2004 [cited 2010 Jan 3]. http://www.pasteur.fr/sante/clre/cadrecnr/Lepto-2006.pdf.
- Herrmann-Storck C, Postic D, Lamaury I, Perez JM. Changes in epidemiology of leptospirosis in 2003–2004, a two El Niño Southern Oscillation period, Guadeloupe archipelago, French West Indies. Epidemiol Infect. 2008;136:1407–15.
- Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14:296–326.
- Postic D, Merien F, Perolat P, Baranton G. Biological diagnosis: leptospirosis–Lyme borreliosis, 2nd ed. Paris: Pasteur Institute; 2000. p. 181–3.
- Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974–1998. Clin Infect Dis. 2001;33:1834–41.
- Faine S. Leptospirosis. In: Evans AS, Brachman PS, editors. Bacterial infections of humans: epidemiology and control, 3rd ed. New York: Plenum; 1998. p. 395–420.
- Chidambaram N, Ramanathan M, Anandi V, Sasikala S, Innocent DJ, Sarayu L. Leptospirosis: clinical presentation and correlation with serovars. J Commun Dis. 2007;39:105–8.
- Edwards CN, Nicholson GD, Hassell TA, Everard CO, Callender J. Leptospirosis in Barbados. A clinical study. West Indian Med J. 1990;39:27–34.
- Dupont H, Dupont-Perdrizet D, Perie JL, Zehner-Hansen S, Jarrige B, Desjardin JB. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis. 1997;25:720–4.
- Everard CO, Bennett S, Edwards CN, Nicholson GD, Hassell TA, Carrington DG, An investigation of some risk factors for severe leptospirosis on Barbados. J Trop Med Hyg. 1992;95:13–22.
- Strobel M. Leptospirosis in Guadeloupe: clinical, biological and epidemiological presentation. Med Mal Infect. 1992;22:648–5l.
- Matthias MA, Levett PN. Leptospiral carriage by mice and mongooses on the island of Barbados. West Indian Med J. 2002;51:10–3.
- Pertuiset E, Fen Chong M, Duval G, Genin R. Clinical aspects and prognostic factors of icterohemorrhagic leptospirosis in adults. Apropos of 249 cases in La Reunion [in French]. Rev Med Interne. 1988;9:487–93.
- Abgueguen P, Delbos V, Blanvillain J, Chennebault JM, Cottin J, Fanello S, Clinical aspects and prognostic factors of leptospirosis in adults. Retrospective study in France. J Infect. 2008;57:171–8.
- Table 1. Demographic, epidemiologic, and clinical characteristics as a function of severity among 168 case-patients with confirmed leptospirosis, Hospital of Pointe-à-Pitre, Guadeloupe, French West Indies, 2003–2004
- Table 2. Laboratory findings for 168 case-patients with confirmed leptospirosis, Hospital of Pointe-à-Pitre, Guadeloupe, French West Indies, 2003–2004
Suggested citation for this article: Herrmann-Storck C, Saint Louis M, Foucand T, Lamaury I, Deloumeaux J, Baranton G. Severe leptospirosis in hospitalized patients, Guadeloupe. Emerg Infect Dis [serial on the Internet]. 2010 Feb [date cited]. http://wwwnc.cdc.gov/eid/article/16/2/09-0139
Please use the form below to submit correspondence to the authors or contact them at the following address:
Cécile Herrmann-Storck, Microbiology Department CHU of Pointe-à-Pitre 97139 Pointe-à-Pitre, Guadeloupe, France
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 10, 2010
- Page last updated: December 10, 2010
- Page last reviewed: December 10, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)